No immediate action is required. Monitor for any follow-up filings that may contain more detailed information about the shareholder vote.
LXRX drugs
LXRX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 17 $1.62entry
- T+1 · 8mo ago −3.70%α −2.31% · $1.56
- T+5 · 8mo ago +6.17%α +8.83% · $1.72
- T+20 · 7mo ago +14.81%α +10.51% · $1.86
- T+60 · 5mo ago +16.05%α +6.19% · $1.88
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Lexicon Pharmaceuticals, Inc. has filed a definitive additional materials proxy statement (DEFA14A) related to a shareholder vote. The filing appears to be routine and does not contain material financial information or indicate an activist campaign.
Key Facts
- Filing is a DEFA14A, which is a definitive additional materials proxy statement.
- The filing is routine and does not contain material financial data.
- No activist campaign or significant corporate action is indicated in the available documents.
Financial Impact
No material financial impact is indicated in the filing.
Risk Factors
- The filing is routine, but the lack of detailed information in the available documents makes it difficult to assess the specific matters to be voted on.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001062822-26-000057 |
| Document: 0001062822-26-000057-index-headers.html | 0001062822-26-000057 |
| Document: 0001062822-26-000057-index.html | 0001062822-26-000057 |
| Document: 0001062822-26-000057.txt | 0001062822-26-000057 |
Track record
16 reports on LXRX
4 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +27.52% at T+20 after the Sep 22, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $1.61 to $1.78 Now $1.75 +8.70% ▲ +10.56% +10.25% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 No price data
- Nov 5, 202611d ago Press Release Neutral 4/10 Entry $1.61 to $1.78 Now $1.75 +8.70% ▲ +10.56% +10.25% vs SPY
- Sep 22, 20267w ago Institutional Cluster Bearish 4/10 Entry $2.18 to $2.06 Now $1.75 +19.72% ▲ +5.50% +4.78% vs SPY
- Aug 6, 202614w ago 8-K Neutral 5/10 No price data
- Aug 6, 202614w ago Press Release Neutral 5/10 Entry $2.36 to $2.47 Now $1.75 −25.85% ▲ +4.66% +4.05% vs SPY
- Jun 12, 202622w ago Institutional Cluster Bearish 5/10 Entry $1.92 to $1.96 Now $1.75 +8.85% ▼ −2.08% −0.32% vs SPY
- Jun 11, 202622w ago Institutional Cluster Neutral 2/10 Entry $1.89 to $1.92 Now $1.75 −7.41% ▲ +1.59% +1.05% vs SPY
- May 6, 202627w ago 8-K Neutral 4/10 Entry $1.68 to $1.68 Now $1.75 +4.17% · 0.00% −0.83% vs SPY
- Apr 30, 202628w ago 8-K Bearish 6/10 Entry $1.63 to $1.60 Now $1.75 −7.36% ▲ +1.84% +1.50% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers